Cargando…
Evaluation of clinical outcome measures for HAM/TSP
Autores principales: | Kikuchi, Takayuki, Sawabe, Aika, Negishi, Yui, Noda, Airi, Hirai, Yuji, Inoue, Eisuke, Kimura, Miyuna, Sato, Kentaro, Araya, Natsumi, Yagishita, Naoko, Sato, Tomoo, Yamano, Yoshihisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577725/ http://dx.doi.org/10.1186/1742-4690-12-S1-P67 |
Ejemplares similares
-
Characteristics of HAM/TSP after kidney transplantation from HTLV-1 positive living donors
por: Kimura, Miyuna, et al.
Publicado: (2015) -
Clinical subtype of HAM/TSP based on clinical course and laboratory findings
por: Yamano, Yoshihisa, et al.
Publicado: (2011) -
Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
por: Tsutsumi, Shuntaro, et al.
Publicado: (2019) -
The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
por: Araya, Natsumi, et al.
Publicado: (2011) -
Patient satisfaction survey for HAM-net registrants
por: Sato, Kentaro, et al.
Publicado: (2015)